Literature DB >> 24715146

Ditopic bis-terdentate cyclometallating ligands and their highly luminescent dinuclear iridium(III) complexes.

Pierre-Henri Lanoë1, Chi Ming Tong, Ross W Harrington, Michael R Probert, William Clegg, J A Gareth Williams, Valery N Kozhevnikov.   

Abstract

A new family of bridged cyclometallating ligands is reported, which incorporate two terdentate N(∧)C(∧)N-coordinating binding sites linked via pyrazine, pyrimidine or pyridazine units. Dinuclear Ir(III) complexes of one ligand have been prepared and crystallographically characterised; they display intense red phosphorescence.

Entities:  

Year:  2014        PMID： 24715146     DOI： 10.1039/c4cc01808g

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  4 in total

1.  Synthesis and luminescence modulation of pyrazine-based gold(III) pincer complexes.

Authors:  Julio Fernandez-Cestau; Benoît Bertrand; Maria Blaya; Garth A Jones; Thomas J Penfold; Manfred Bochmann
Journal:  Chem Commun (Camb)       Date:  2015-10-01       Impact factor: 6.222

2.  An Unprecedented Family of Luminescent Iridium(III) Complexes Bearing a Six-Membered Chelated Tridentate C^N^C Ligand.

Authors:  Claus Hierlinger; Thierry Roisnel; David B Cordes; Alexandra M Z Slawin; Denis Jacquemin; Véronique Guerchais; Eli Zysman-Colman
Journal:  Inorg Chem       Date:  2017-04-10       Impact factor: 5.165

3.  Highly luminescent palladium(ii) complexes with sub-millisecond blue to green phosphorescent excited states. Photocatalysis and highly efficient PSF-OLEDs.

Authors:  Pui-Keong Chow; Gang Cheng; Glenna So Ming Tong; Chensheng Ma; Wai-Ming Kwok; Wai-Hung Ang; Clive Yik-Sham Chung; Chen Yang; Feng Wang; Chi-Ming Che
Journal:  Chem Sci       Date:  2016-06-15       Impact factor: 9.825

4.  Pyridazine-bridged cationic diiridium complexes as potential dual-mode bioimaging probes.

Authors:  Ruth E Daniels; Luke K McKenzie; Jonathan R Shewring; Julia A Weinstein; Valery N Kozhevnikov; Helen E Bryant
Journal:  RSC Adv       Date:  2018-03-06       Impact factor: 3.361
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.